Category
25 plain-language articles on hormonal and endocrine — the physiology, the compounds, and what the evidence actually shows.
25 articles
The low-libido story that isn't about the relationship
The relationship is fine. The attraction is intact. There is nothing obvious wrong, and yet desire has gone quiet. Arousal takes longer to arrive, or doesn't fully arrive. Bodies that used to want each other now feel mostly tired. The conversation, when it happens at all, tends to move quickly into emotional explanations — distance, resentment, mismatched needs — when often the upstream signal is much simpler and much more physiological.
Low T that isn't really low T — the functional hypogonadism story
Libido is gone. Recovery from training takes a week instead of a day. Mood has flattened. Muscle that used to come back doesn't. You ask for a testosterone panel expecting confirmation, and it comes back "normal" — maybe low-normal, maybe mid-range, but inside the reference interval. The clinician shrugs. You leave with the symptoms you walked in with and no explanation. The mechanism is real, and it has a name.
Prostate inflammation and the autonomic nervous system
Nocturia three or four times a night. A weaker stream. The sense of incomplete emptying. A persistent low-grade pelvic discomfort that the imaging doesn't quite explain. Most men with these symptoms are told they have benign prostatic hyperplasia or chronic prostatitis, are offered an alpha-blocker or a 5-alpha-reductase inhibitor, and are sent on their way. The structural diagnosis is often correct. It's also often incomplete — because the prostate sits at a junction where structure, hormones, and the autonomic nervous system meet, and the symptom load is rarely produced by structure alone.
Why your testosterone test is normal but you still feel terrible
The energy is gone. Libido is flat or absent. Workouts that used to feel productive now feel like punishment, and the recovery between them stretches into days. Motivation has thinned to something brittle. You finally get the testosterone panel pulled, and the number comes back inside the reference range. Your clinician tells you everything looks fine. You leave knowing it isn't, and with no language for what's actually happening.
Argipressin (vasopressin) — what the antidiuretic hormone does in acute care
The patient's blood pressure has been falling for hours. The ICU team has given norepinephrine, then more norepinephrine, then more again. The vasopressors are doing less than they should. At some point in that sequence, the intensivist reaches for a different molecule — one that works through a different receptor pathway entirely, one that the body normally makes itself, one that has been sitting in the endocrine system since before mammals had an immune response evolved enough to produce septic shock. Vasopressin. The decision to add it to the norepinephrine drip isn't dramatic; it happens in a sentence in the order set. But the pharmacology behind that decision reaches back to some of the most fundamental biology of fluid and pressure regulation in vertebrates.
Your body temperature has stopped regulating — what the cold hands and night sweats are telling you
Your hands are cold right now. They're cold in the office when everyone else is comfortable. Cold in the car before the heat kicks in, and still cold after. You wear a cardigan in July and your colleagues look at you like you're performing. Then, at two in the afternoon, something shifts — a flush moves through your chest and neck, not dramatic, not the full-face red of embarrassment, but unmistakable, and you need to take off the cardigan. By evening you're comfortable. By three in the morning you wake drenched, the sheets changed, pillow turned over, lying still waiting for a body temperature that feels like it belongs to someone who's running a fever and trying to hide it. By morning you're cold again.
Cold hands and feet all the time — what's happening at the small vessels
The room is warm. It's summer, or the heat is on, or you're wearing socks and have been sitting still for an hour. And your hands are still cold. The fingers don't warm up the way everyone else's seem to — you shake someone's hand and they notice, or you put your feet against your partner at night and they flinch. Sometimes the color changes. The fingertips go white when you step outside, then take on a bluish cast, then flush back to pink in a way that happens too visibly and too dramatically for weather that shouldn't be doing this. And when you mention it to a doctor, the response is usually some version of: some people just run cold.
Gonadorelin in plain English — GnRH and the pituitary feedback loop
Before you had a single reproductive hormone in your bloodstream, before your gonads had ever been activated, a handful of neurons in your hypothalamus were already learning to fire in a rhythm. Not continuously — in pulses. A burst of electrical activity every hour or two, releasing a ten-amino-acid peptide into the pituitary portal blood, which carried it the short distance to the pituitary gland, which responded by releasing LH and FSH. This pulse had to be irregular enough to feel like a signal rather than background noise. It had to arrive, be recognized, and then stop — so the pituitary's receptors could reset and be ready for the next one. The hypothalamus spent years calibrating this rhythm before puberty began. That rhythm is what started everything else.
Beyond the Thyroid: How Hashimoto's Damages the Gut and Starves You of Iron
Most people with Hashimoto's are told a simple story: the immune system attacks the thyroid, the thyroid slows down, you take levothyroxine, done. That story is incomplete in a way that matters. Hashimoto's is frequently a two-organ disease. The same autoimmune process that goes after the thyroid often goes after the stomach, and the stomach is where iron absorption lives or dies.
What people are reporting about HCG on TRT and during PCT
This article summarizes experiences reported in public online communities including Reddit, longevity forums, and discussion boards. We are not advocating human use of any compound discussed here. Many of the peptides discussed are not FDA-approved for the uses described, and some are explicitly not approved for human or veterinary use. What follows is a synthesis of what people have reported, presented to give readers context on the public conversation — not as guidance, not as evidence of safety or efficacy, and not as a recommendation. Decisions about any compound should be made with a qualified prescribing provider after a full medical evaluation.
HCG in plain English — what LH mimicry actually does
In 1927, two scientists named Selmar Aschheim and Bernhard Zondek discovered that injecting urine from pregnant women into immature female mice caused ovarian development — something that shouldn't have happened in animals that hadn't yet reached sexual maturity. They had stumbled onto evidence of a powerful hormonal signal being excreted in pregnancy urine in large quantities. That signal turned out to be human chorionic gonadotropin, and for decades it was extracted from the urine of pregnant women and used as a pharmaceutical. The fact that it worked — and kept working across a remarkable range of clinical applications — suggested something important about its mechanism. HCG was not mimicking a signal that existed only in pregnancy. It was speaking a language the body's own endocrine receptors already understood fluently.
HCG in TRT — preserving fertility on testosterone
You've been on testosterone replacement therapy for eighteen months and everything is better — energy, mood, muscle, libido, the general feeling that your body is working again. Then you and your partner decide to try to conceive, and you mention this to your prescribing provider, and the news is not what you expected. Or maybe the news arrived earlier, more abruptly: you went in for a checkup, the doctor commented on your testicular atrophy, and the word "infertility" entered the conversation before you'd thought to ask. Either way, the version of TRT you'd been sold — or had sold yourself — turned out to have a cost no one made very clear at the start.
HCG vs gonadorelin vs enclomiphene — the TRT-adjunct decision tree
Your prescribing provider has explained that starting testosterone replacement will suppress your body's own hormonal axis. Your LH will drop toward zero. Your testes will stop producing their own testosterone. Spermatogenesis will slow. And if you want to preserve any of that — fertility, testicular volume, the option of coming off someday — you'll need to do something alongside the testosterone, not just instead of it. Then they hand you a choice that nobody warned you would exist. Three options. Different mechanisms. Different drawbacks. The provider lays them out and you realize you're making a pharmacological decision without quite enough information to make it well.
How to read a thyroid panel — TSH, free T4, free T3, reverse T3, and antibodies
You get the call from your doctor's office. Everything looks normal. Your thyroid panel is fine. And you hang up the phone and sit with the particular frustration of someone whose symptoms — the fatigue that doesn't lift with sleep, the cold hands and feet in a warm room, the hair that comes out in the brush, the weight that resists every reasonable effort, the brain that feels like it's loading slowly — have just been told, politely, that they don't exist. Or at least that the labs don't show anything.
Kisspeptin-10 — upstream of GnRH and the libido conversation
In 1996, a team of researchers studying cancer metastasis in malignant melanoma identified a gene that, when present in tumor cells, suppressed their ability to spread to other tissues. They named it KiSS-1, after Hershey, Pennsylvania — the birthplace of the study's lead researcher and home of the Hershey Kiss. The gene was interesting as an oncology finding, catalogued alongside other metastasis-suppressor genes, and largely forgotten outside that narrow field for several years. Nobody expected it to turn out to be the master switch for the entire human reproductive system.
Low T that isn't really low T — the functional hypogonadism story
The lab report comes back and the number in the testosterone row says 452. The reference range printed next to it says 264–916. You are, by every metric the lab can offer, normal. And yet you are exhausted in a way that sleep doesn't fix. Your libido is a fraction of what it was. You've lost muscle despite consistent training, or you can't gain it the way you used to. Your mood has a flatness to it, a dimmer quality, an absence of the drive and edge that used to feel like your baseline. You bring this to your doctor. The labs come back normal. You're told it's stress, or aging, or depression. You might be given an antidepressant. What you are almost certainly not given is an explanation for why a total testosterone of 452 can produce a clinical picture indistinguishable from classical hypogonadism.
Male fertility on TRT — the options nobody told you about
You started TRT for reasons that made sense. Your testosterone was low, your symptoms were real, and the decision to treat was made carefully with a provider you trusted. The fatigue lifted. The body composition shifted. The mood improved. The quality of life difference was genuine and significant. You don't regret the decision. And then you and your partner decide to try for a child, and the semen analysis comes back with a sperm count near zero. Or the fertility clinic, doing a baseline workup, finds azoospermia — no sperm at all. And you have, for the first time, a clear view of a consequence that your original TRT conversation may have entirely omitted.
What people are reporting about Melanotan II over years
This article summarizes experiences reported in public online communities including Reddit, longevity forums, and discussion boards. We are not advocating human use of any compound discussed here. Many of the peptides discussed are not FDA-approved for the uses described, and some are explicitly not approved for human or veterinary use. What follows is a synthesis of what people have reported, presented to give readers context on the public conversation — not as guidance, not as evidence of safety or efficacy, and not as a recommendation. Decisions about any compound should be made with a qualified prescribing provider after a full medical evaluation.
Melanotan II and the dysplastic mole question — what the dermatology literature shows
You notice it in the shower one morning, the way you notice things that weren't there before and then suddenly are: a mole that looks different. Darker than it was. Maybe bigger. You think about it for a day, tell yourself it's nothing, think about it again the next day. You go to the dermatologist. You have been using Melanotan II for six weeks. You are starting to wonder whether the two things are connected, and you are not wrong to wonder.
The midlife testosterone slide — what's normal aging and what's not
You notice it first in the gym. Recovery takes a day longer than it used to, then two. The weight you were pressing in January feels heavier in April despite consistent training. You're leaner than you were at 25, eating better, sleeping reasonably — and yet something in the machine has changed. The mornings are different too. The erection you used to wake up with reliably is less reliable. Your mood isn't bad exactly, it's flatter — motivation thinner, the drive to push and compete and initiate quieter than it was. Libido is there, but it's turned down. You don't feel like something is wrong. You just don't feel like yourself.
Post-cycle therapy in plain English — what it is and why it matters
You've stopped. Whether you made the decision yourself, were advised to by a provider ending a supervised TRT course, or simply reached the point where the consequences outweighed the benefits — you've come off exogenous testosterone or anabolic steroids, and now you're waiting for your body to restart something it stopped doing while the external supply was running. The waiting is not comfortable. Energy is low. Mood is poor in the particular way that insufficient testosterone produces — not quite depression, more like a sustained deflation, a thinning of the world. Libido is absent. The body feels different and not in a good way. You've been told it'll come back on its own, and that's true in principle. In practice, the question of how long, how completely, and what you can do to support the process — these are questions that deserve real answers rather than reassurance.
Seractide / ACTH 1-39 — adrenal function testing in plain English
You've been fatigued for two years. Not tired — fatigued. The kind where waking up doesn't end it, where the second half of every day feels like dragging yourself through something thick, where you've stopped scheduling things in the afternoon because you know you'll be useless. The labs your primary care doctor ran came back "normal." But normal relative to what, and for whom, and measured at what time of day — those questions don't usually get asked. If they do get asked, eventually someone orders an ACTH stimulation test, and what that test measures is more specific and more useful than most fatigue workups. Understanding what it's doing requires understanding the gland it's interrogating.
The isolation of testosterone — Adolf Butenandt and the 1935 Nobel
On the first of June, 1889, Charles-Édouard Brown-Séquard stood before the Société de Biologie in Paris and described what he had done to himself. He was 72 years old, a neurologist of considerable distinction — he had been Jean-Martin Charcot's predecessor at the Salpêtrière, he had described the hemisensory syndrome that still bears his name — and he had spent the previous months injecting himself with a fluid he had prepared from the crushed testicles and testicular blood of dogs and guinea pigs. He reported that he felt thirty years younger. His intellectual energy had returned, his physical strength had improved, his digestion was better. He could run upstairs. He could work longer hours.
Night sweats that aren't menopause — what else drives them
You wake at 3am and the sheets are soaked through. Not warm — drenched. There's a chill at the edge of it because the room is cool, the window is open, and your body has generated enough heat to saturate the fabric underneath you. You change the shirt. Sometimes the sheets. Sometimes you lie there damp and try to figure out what just happened. It may have happened the night before too, and the night before that. Your partner hasn't noticed anything wrong with the room temperature. It's specifically you.
The water you can't drink enough of — what unrelenting thirst is signaling
You finish the glass and you're already thinking about the next one. The water bottle is never far, and it never seems to land — you drink and drink and the dryness in your mouth just resurfaces, a low background thirst that follows you through the afternoon. At night it wakes you: a parched mouth, tongue stuck to the roof of it, and the walk to the kitchen, and then the walk to the bathroom that feels like it comes around more often than the math of what you drank should allow. In the morning you do it again. It doesn't feel like ordinary thirst. It feels like a thing that won't be answered.